These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10362395)

  • 41. Effects of N-methyl-L-arginine on cardiac and regional blood flow in a dog endotoxin shock model.
    Doursout MF; Kilbourn RG; Hartley CJ; Chelly JE
    J Crit Care; 2000 Mar; 15(1):22-9. PubMed ID: 10757195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aminoethyl-isothiourea in gram-positive shock: an inhibitor of inducible nitric oxide synthase or a jack-of-all-trades?
    Thiemermann C
    Shock; 2001 Jun; 15(6):453-4. PubMed ID: 11386617
    [No Abstract]   [Full Text] [Related]  

  • 43. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock.
    Kang JS; Yoon YD; Cho IJ; Han MH; Lee CW; Park SK; Kim HM
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1187-94. PubMed ID: 15537821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of vasoactive intestinal peptide (VIP) and inhibition of nitric oxide synthase on survival rate in rats exposed to endotoxin shock.
    Tunçel N; Töre FC
    Ann N Y Acad Sci; 1998 Dec; 865():586-9. PubMed ID: 9928074
    [No Abstract]   [Full Text] [Related]  

  • 45. Methylene blue infusion in septic shock.
    Marczin N; Tekeres M; Salzman AL; Szabó C
    Crit Care Med; 1995 Nov; 23(11):1936-8. PubMed ID: 7587277
    [No Abstract]   [Full Text] [Related]  

  • 46. Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock.
    Rosselet A; Feihl F; Markert M; Gnaegi A; Perret C; Liaudet L
    Am J Respir Crit Care Med; 1998 Jan; 157(1):162-70. PubMed ID: 9445295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.
    Cobb JP; Natanson C; Hoffman WD; Lodato RF; Banks S; Koev CA; Solomon MA; Elin RJ; Hosseini JM; Danner RL
    J Exp Med; 1992 Oct; 176(4):1175-82. PubMed ID: 1383377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening.
    Xu C; Yi C; Wang H; Bruce IC; Xia Q
    Shock; 2012 Jan; 37(1):110-5. PubMed ID: 21993446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nitric oxide--a basic mediator of vasodilation and septic shock].
    Vasilev D; Karadimov D; Vogt J; Santak B
    Khirurgiia (Sofiia); 1996; 49(4):14-6. PubMed ID: 8968135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nitric oxide in sepsis-syndrome: potential treatment of septic shock by nitric oxide synthase antagonists.
    Ketteler M; Cetto C; Kirdorf M; Jeschke GS; Schäfer JH; Distler A
    Kidney Int Suppl; 1998 Feb; 64():S27-30. PubMed ID: 9475485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.
    Robertson FM; Offner PJ; Ciceri DP; Becker WK; Pruitt BA
    Arch Surg; 1994 Feb; 129(2):149-55; discussion 155-6. PubMed ID: 7508219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic effects of erythropoietin in murine models of endotoxin shock.
    Vollmar B; Eipel C; Menger MD
    Crit Care Med; 2010 Jan; 38(1):340-1. PubMed ID: 20023499
    [No Abstract]   [Full Text] [Related]  

  • 53. Involvement and dual effects of nitric oxide in septic shock.
    Wolkow PP
    Inflamm Res; 1998 Apr; 47(4):152-66. PubMed ID: 9628258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of nitric oxide in endotoxic shock. An overview of recent advances.
    Szabó C
    Ann N Y Acad Sci; 1998 Jun; 851():422-5. PubMed ID: 9668635
    [No Abstract]   [Full Text] [Related]  

  • 55. β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock.
    Kimmoun A; Louis H; Al Kattani N; Delemazure J; Dessales N; Wei C; Marie PY; Issa K; Levy B
    Crit Care Med; 2015 Sep; 43(9):e332-40. PubMed ID: 25962080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitric oxide and septic shock. From bench to bedside.
    Kuhl SJ; Rosen H
    West J Med; 1998 Mar; 168(3):176-81. PubMed ID: 9549416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nitric oxide in septic shock.
    Titheradge MA
    Biochim Biophys Acta; 1999 May; 1411(2-3):437-55. PubMed ID: 10320674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aminoethyl-isothiourea, a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock.
    Saetre T; Höiby EA; Aspelin T; Lermark G; Egeland T; Lyberg T
    Crit Care Med; 2000 Aug; 28(8):2697-706. PubMed ID: 10966238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nitric oxide supports atrial function in sepsis: relevance to side effects of inhibitors in shock.
    Price S; Evans TW; Mitchell JA
    Eur J Pharmacol; 2002 Aug; 449(3):279-85. PubMed ID: 12167470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental and emerging therapies for sepsis and septic shock.
    Añel RL; Kumar A
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1471-85. PubMed ID: 11772263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.